美国 · 新闻 · The Hill
FDA: Mifepristone review won’t be done until March
The Food and Drug Administration (FDA) won’t publish its safety review of the abortion drug mifepristone until March, it disclosed in a Wednesday court filing, adding that it…
在 The Hill 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (thehill.com)




